Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension

被引:1
作者
Rosenzweig, EB [1 ]
Barst, RJ [1 ]
机构
[1] Babies & Childrens Hosp New York, New York Presbyterian Hosp, Div Pediat Cardiol, New York, NY 10032 USA
关键词
endothelin receptor antagonists; paediatrics; prostacyclin; prostacyclin analogues; pulmonary arterial hypertension; pulmonary vasodilator treatment;
D O I
10.1517/13543784.10.5.811
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The treatment of paediatric pulmonary arterial hypertension is challenging due to the serious nature of the disease, its rapid progression and the limited treatment options available. However. recent advances in the treatment of pulmonary arterial hypertension may offer significant improvements for patients suffering from this condition. Novel treatment options include prostacyclin analogues and endothelin receptor antagonists. A comprehensive review of the nem er agents, with an emphasis on the pathobiology/pathophysiology of pulmonary arterial hypertension provides insight into future management of paediatric pulmonary arterial hypertension.
引用
收藏
页码:811 / 823
页数:13
相关论文
共 75 条
[1]   VASODILATOR ACTIONS OF TRK-100, A NEW PROSTAGLANDIN-I2 ANALOG [J].
AKIBA, T ;
MIYAZAKI, M ;
TODA, N .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (04) :703-711
[2]  
BADESCH DB, 2000, ANN INTERN MED, V132, P125
[3]  
Barst RJ, 2000, EUR HEART J, V21, P315
[4]   Vasodilator therapy for primary pulmonary hypertension in children [J].
Barst, RJ ;
Maislin, G ;
Fishman, AP .
CIRCULATION, 1999, 99 (09) :1197-1208
[5]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[6]  
Barst RJ, 2000, CIRCULATION, V102, P427
[7]   SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN [J].
BARST, RJ ;
RUBIN, LJ ;
MCGOON, MD ;
CALDWELL, EJ ;
LONG, WA ;
LEVY, PS .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :409-415
[8]  
BARST RJ, 2001, IN PRESS CHEST
[9]  
BARST RJ, 2000, IN PRESS CIRCULATION
[10]  
BERMANROSENZWEI.E, 1999, CIRCULATION, V99, P1858